Thymic Stromal Lymphopoietin: To Cut a Long Story Short.

Tsilingiri, Katerina; Fornasa, Giulia; Rescigno, Maria

Tsilingiri, Katerina; Fornasa, Giulia; Rescigno, Maria.

Affiliation

Tsilingiri K; Vascular Pathophysiology Area, Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.
Fornasa G; Department of Experimental Oncology, European Institute of Oncology, Milan, Italy and University of Milan.
Rescigno M; Department of Experimental Oncology, European Institute of Oncology, Milan, Italy and University of Milan.

Cell Mol Gastroenterol Hepatol ; 3(2): 174-182, 2017 Mar.

Article in En | MEDLINE | ID: mdl-28275684

Key words

Atopic Diseases; DC, dendritic cell; Gut Homeostasis; IFN, interferon; IL, interleukin; ILC, innate lymphoid cells; MAPK, mitogen-activated protein kinase; NF-κB, nuclear factor kappa B; TLR, toll-like receptor; TNF, tumor necrosis factor; TSLP, thymic stromal lymphopoietin; TSLPR, thymic stromal lymphopoietin protein receptor; Therapeutic Targets; Thymic Stromal Lymphopoietin; Treg, regulatory T cells

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Cell Mol Gastroenterol Hepatol Year: 2017 Type: Article Affiliation country: Spain

Fulltext

XML

PubMed Links

Search on Google